MHRA approves bivalent COVID-19 booster vaccine made by Pfizer/BioNTech

A second, "bivalent" vaccine has today been approved as a booster by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

Related Keywords

United Kingdom ,June Raine ,Munir Pirmohamed ,Emily Henderson ,Committee On Vaccination ,Commission On Human Medicines ,Vaccines Expert Working Group ,Regulatory Agency ,Human Medicines ,United Kingdom Autumn ,United Kingdom Approved ,Sir Munir Pirmohamed ,Expert Working Group ,Joint Committee ,Covid 19 ,Clinical Trial ,Coronavirus ,Healthcare ,Immune Response ,Micron ,Vaccine ,Virus ,